GLUE Lecture | The Next Generation of Lateral Flow Assays: Integration of Nanomaterials - POCTRN
Center news
GLUE Lecture | The Next Generation of Lateral Flow Assays: Integration of Nanomaterials
About the Speaker
Arben Merkoçi, PhD is currently ICREA Professor and director of the Nanobioelectronics & Biosensors Group at Institut Català de Nanociencia i Nanotecnologia (ICN2), a BIST center situated at Autonomous University of Barcelona (UAB) campus. Prof. Merkoçi’s research is focused on the design and application of cutting-edge nanotechnology and nanoscience-based biosensors with interest for diagnostics. These nanobiosensors are based on the integration of biological molecules (DNA, antibodies, cells, and enzymes) and other (bio)receptors with micro- and nanostructures and applied in diagnostics, environmental monitoring or safety and security.
About the GLUE Lecture Series
The Oliver Brand Memorial Lecture Series includes Global Lectures Uniting Everyone (GLUE) which is the Atlanta Center for Microsystems Engineered Point-of-care Technologies (ACME POCT) flagship event series. These talks serve as our primary venue to educate on the entrepreneurial pathway and product lifecycle. It provides a forum to pitch clinical problems and teach about the technologies most promising for meeting these clinical needs.
When:
Wednesday, January 10, 2024
10:30AM ET
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness